Holen Sie sich die Stockscreener-App
2.24
3.23%
0.07
Schlusskurs vom Vortag:
$2.17
Offen:
$2.2
24-Stunden-Volumen:
1.05M
Relative Volume:
0.75
Marktkapitalisierung:
$430.28M
Einnahmen:
$199.19M
Nettoeinkommen (Verlust:
$-16.02M
KGV:
-26.45
EPS:
-0.0847
Netto-Cashflow:
$168.00K
1W Leistung:
+1.82%
1M Leistung:
-11.11%
6M Leistung:
+68.42%
1J Leistung:
+24.44%
1-Tages-Spanne:
$2.17
$2.33
1-Wochen-Bereich:
$2.045
$2.33
52-Wochen-Spanne:
$1.12
$2.955
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.24 | 416.83M | 199.19M | -16.02M | 168.00K | -0.0847 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
Market Wrap: Is VLGEAs ROE strong enoughQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Cerus (CERS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Cerus (NASDAQ:CERS) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Cerus director Timothy L. Moore to step down after 2026 annual meeting - Investing.com
New German trial tests safer platelets for cancer patients - stocktitan.net
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice - ChartMill
Sumitomo Mitsui Trust Group Inc. Lowers Stock Holdings in Cerus Corporation $CERS - MarketBeat
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Cerus (NASDAQ:CERS) Sets New 52-Week HighWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA) - The Globe and Mail
TD Cowen reiterates Buy rating on Cerus stock after strong Q4 results - Investing.com
CERS Projects Revenue Growth in 2026 - GuruFocus
Cerus (CERS) Reports Significant Global Expansion of INTERCEPT B - GuruFocus
Cerus (CERS) Reports Strong Revenue Growth Driven by INTERCEPT F - GuruFocus
Cerus expects 14% jump in 2025 topline, guides 2026 (CERS:NASDAQ) - Seeking Alpha
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Yahoo Finance
Revenue Check: Why Cerus Corporation stock is recommended by analysts2025 Volume Leaders & Risk Controlled Daily Trade Plans - Улправда
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving Average – Should You Sell? - Defense World
2026 world cup canada semifinals top scorers low block match prediction analysisMarket Risk Summary & AI Driven Price Forecasts - ulpravda.ru
What hedge fund activity signals for CNVS stockWeekly Gains Report & Safe Entry Zone Identification - ulpravda.ru
What insider trading reveals about Cerus Corporation stockMarket Volume Report & Verified Chart Pattern Trade Signals - Улправда
2026 world cup team news tips: Why Cerus Corporation stock is recommended by analysts2026 world cup usa national team quarterfinals young talents set piece tactics knockout prediction guide - ulpravda.ru
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) - Finviz
Assenagon Asset Management S.A. Purchases 358,548 Shares of Cerus Corporation $CERS - Defense World
Analysts’ Top Healthcare Picks: Cerus (CERS), Entera Bio (ENTX) - The Globe and Mail
Financial Analysis: Cerus (NASDAQ:CERS) vs. PURE Bioscience (OTCMKTS:PURE) - Defense World
Cerus (CERS): Strong Growth Potential and Increased Valuation - GuruFocus
Can Cerus Corporation (CU2) stock test all time highs2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Улправда
Can Cerus Corporation stock resist market sell offsJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
Cerus announces group purchasing pact with Blood Centers of America - MSN
Will Cerus Corporation stock beat EPS estimatesJuly 2025 Technicals & Short-Term Swing Trade Alerts - Улправда
Why Cerus Corporation stock is recommended by analystsJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
Cerus Corporation (NASDAQ:CERS) Stock Catapults 33% Though Its Price And Business Still Lag The Industry - 富途牛牛
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Cerus Shares Surge on Strategic Deal and Financial Momentum - AD HOC NEWS
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Cerus Corporation CU2 Stock Analysis and ForecastEvening Star Patterns & Exceptional Capital Trading - earlytimes.in
Cerus signs purchasing agreement with Blood Centers of America By Investing.com - Investing.com Nigeria
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America - Bakersfield.com
Cerus signs purchasing agreement with Blood Centers of America - Investing.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Promising Penny Stocks To Watch In December 2025 - simplywall.st
Perhaps timely catching Cerus Corp (CERS) would be a good idea - setenews.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Cerus Corp (NASDAQ:CERS) Nasdaq Composite Global Safety Systems - Kalkine Media
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):